BGC1614
BGC1614 is a Nectin-4-targeting bicyclic toxin conjugate (BTC) belonging to the category of peptide-drug conjugates (PDCs). BGC1614 exhibits strong targeted binding ability to Nectin-4, with an KD of 3.859 × 10-7 M. BGC1614 exhibits superior antitumor efficacy in nude mice bearing PC-3 and N87 tumor xenografts. BGC1614 can be used for research related to Nectin-4-overexpressing tumors (such as prostate cancer, gastric cancer).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C387H582N94O104S7
- Masse moléculaire:8439.78
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:PC-3 or N87 cells were implanted into nude mice[1]
-
Dosage:1.0, 3.0 mg/kg
-
Administration:i.v., once a week, 21 days
-
Result:Achieved tumor growth inhibition (TGI) rates of 96.3% in nude mice bearing PC-3 tumor xenografts.
Achieved tumor growth inhibition (TGI) rates of 41.9% and 70.1% respectively in nude mice bearing N87 tumor xenografts.
Showed no significant changes in body weight.
Chemical Information
-
Masse moléculaire 8439.78
-
Formule C387H582N94O104S7
-
Sequence
Mpa-Pro-Nal-(DAsp)-Cys-Met-hArg-Asp-Trp-Ser-Thr-Pro-HyP-Trp-Cys(TATA covalent with Mpa1,Cys5,Cys15)-Sar10-PEG6-Lys(Lys(N3)-(DBCO-PEG6-βAla-Sar10-Ala-hArg-Asp-Cys-Hyp-Leu-Val-Asn-Pro-Leu-Cys-Leu-His-Pro-(DAsp)-Trp-hArg-Cysteamine, TATA covalent with Cys15,Cys22,Cysteamine 29)-GA-Val-Cit-PABC-MMAE
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)